Novavax Covid-19 Vaccine Over 90% Effective, Study Shows The biotech firm says the vaccine uses a third type of technology.

By Euni Han

Opinions expressed by Entrepreneur contributors are their own.

SOPA Images | Getty Images

Novavax's COVID-19 vaccine showed an overall efficacy of 90.4% in trials and offered 100% protection in some cases, says CEO Stanley Erck in a company release.

"These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection," he wrote.

The vaccine also demonstrated 93% efficacy against circulating variants, says Dr. Gregory M. Glenn, Novovax's President of Research and Development.

Related: Grocery Chain to Give Away $5 million to Vaccinated Customers

"These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Our vaccine will be a critical part of the solution to COVID-19 and we are grateful to the study participants and trial staff who made this study possible."

The trial included 29,960 volunteers in the U.S. and Mexico: 20% were Latin American, 12% were African American, 7% were Native American, 5% were Asian and 13% were over 65 years old. None of the participants receiving the drug fell seriously ill.

Related: These 7 Countries are Now Accepting Vaccine Passports

Common side effects included pain around the injection site, muscle aches and fatigue.

Novavax says its vaccine uses a third type of technology that delivers the protein antigen directly inside the body within tiny particles. A booster then strengthens the body's immune response.

The Gaithersburg, Maryland firm, which received $1.6 billion in federal funding, also says its drug development took longer due to its smaller size, USA TODAY reports.

But once final chemistry, manufacturing and controls requirements are met, Novavax plans to file for regulatory authorization during the summer --- saying its on track to manufacture 100 million doses a month by the end of the third quarter, and 150 million doses a month by the final quarter of 2021.

Related: This robot will tell you when and how to get vaccinated

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Side Hustle

This 29-Year-Old's Side Hustle Brought People 'to the Dark Green Side.' It Made $10,000 Within 2 Days and Sees 6 Figures a Month.

Nikki Seaman began work on her business when the pandemic led to grocery store shutdowns.

Business News

Here's How the CEO of the Biggest Bank in the U.S. Spends His Downtime: 'This Gives Me Purpose in Life'

JPMorgan CEO Jamie Dimon, 69, recently said that his top three priorities are his family, his country, and his purpose, which is working at the bank — in that order.

Side Hustle

How to Build Endless Passive Income With This Simple Online Hustle

Autopilot stores aren't just income streams. They are passports to freedom, flexibility and finally working and living on your own terms.

Leadership

Lead From the Top: 5 Core Responsibilities of a CEO

Knowing exactly what the chief executive's role entails is critical for steering a company to success.

Health & Wellness

This Is the Newest Real Estate Trend You Can't Miss — and It's Worth $438 Billion

A rapidly emerging new trend is sweeping the global real estate sector, powered by humanity's collective desire for longer lives and healthier lifestyles. Here's what entrepreneurs should pay attention to to capture the new market.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.